DHTKD1 is a lesser-studied E1 enzyme belonging to the family of 2-oxoacid dehydrogenases.
INTRODUCTION
into their corresponding acyl-CoA thioester, generating the reducing equivalent NADH. These biochemical reactions play crucial roles in intermediary metabolism, and are tightly regulated by phosphorylation and allosteric effectors [1, 2] .
The overall reaction catalysed by 2-oxoacid dehydrogenases is dissected into three sequential steps each catalysed by an individual enzyme [3, 4] . In the first step, rate-limiting for the overall reaction, the E1 enzyme (a 2-oxoacid decarboxylase; EC 1. To achieve the overall oxidative decarboxylation reaction, multiple copies of the E1, E2 and E3 components classically assemble into a supramolecular complex reaching 4-10 MDa in weight [5] . Structural studies have shown E2 enzymes from various organisms to exist in a high-order cubic 24-mer or dodecahedral 60-mer [6] , acting as a scaffold onto which copies of E1 and E3 are assembled. Such quaternary arrangement, a classic example of a metabolon, provides a means by which products of one reaction are funnelled into the catalytic centres of the next reactions to enhance enzymatic efficiency and avoid undesirable side-reactions [7] . For example, the E2attached dihydrolipoyl cofactor is expected to shuttle catalytic intermediate substrates between
the active sites of E1 and E3 enzymes by means of a 'swinging-arm' mechanism [8] [9] [10] .
The human genome encodes five E1-type decarboxylases (PDH, BCKDH, OGDH, DHTKD1, OGDHL), among which OGDH, OGDHL and DHTKD1 form a more evolutionarily related subgroup with respect to the E1 architecture and the E2 enzyme employed [11] . The OGDHc complex, composed of OGDH as E1, dihydrolipoamide succinyltransferase (DLST) as E2, and DLD as E3, converts the metabolite 2-oxoglutarate (2OG) to succinyl-CoA and serves as a ratelimiting step in the Krebs cycle [12] . A close homologue of OGDH, DHTKD1 (dehydrogenase E1 and transketolase domain-containing protein 1) is positioned in the last step of lysine and tryptophan catabolism with the common product being 2-oxoadipate (2OA), one methylene group longer than 2OG. To catalyse the oxidative decarboxylation of 2OA to glutaryl-CoA [13] , DHTKD1 recruits the same E2 (DLST) and E3 (DLD) as OGDH to form the 2-oxoadipate dehydrogenase complex (OADHc) [14, 15] , implying that DLST also acts as a dihydrolipoamide glutaryltransferase. DHTKD1 [16, 17] joins OGDH [18, 19] as a contributor of reactive oxygen species in the mitochondria via radical formation from a catalytic intermediate. DHTKD1 is increasingly recognized as essential for mitochondrial function and energy production [18, 19] .
In support of this role, inherited DHTKD1 mutations are identified as the molecular cause of two rare Mendelian disorders. 2-Aminoadipic and 2-oxoadipic aciduria (OMIM 204750) is an inborn error of metabolism with questionable clinical consequence [20] , characterized biochemically by increased urinary excretion of 2-oxoadipate and its transamination product 2-aminoadipate [21, 22] . Among < 30 reported cases due to autosomal recessive missense and nonsense mutations [23] , p.Gly729Arg and p.Arg455Gln are common variants. Additionally, a nonsense DHTKD1 mutation causes Charcot-Marie-Tooth disease type 2Q (CMT2Q, OMIM 615025), an autosomal dominant neurodegenerative disorder characterized by motor and sensory neuropathies [24] .
While structural studies have been carried out for PDH and BCKDH E1 enzymes from various organisms across the phyla, including human [25, 26] , only prokaryotic OGDHs have been crystallised. These include the apo structure of E. coli OGDH (ecOGDH) [27] , as well as various structures of Mycobacterium smegmatis OGDH (msOGDH) complexed with active site catalytic intermediates [28] [29] [30] . In this study, we report the crystal structure of human DHTKD1 and a model of the human DLST catalytic core determined by cryo-electron microscopy. We also characterised disease-causing variants of DHTKD1 that destabilise the protein, or disrupt the interaction with DLST.
RESULTS & DISCUSSION

Overall structure of human DHTKD1 homodimer
Human DHTKD1 (hDHTKD1) is a 919-amino acid (aa) polypeptide ( Fig. 1a) , with the Nterminal 22 aa predicted to form the mitochondrial targeting signal peptide [11] . We expressed in E. coli the soluble proteins for the precursor hDHTKD1 1-919 , the predicted mature protein (hDHTKD1 ), as well as a further truncated construct (hDHTKD1 ) removing the putatively disordered aa 24-44 (Suppl. Fig. 1 ). Attempts to crystallise full-length protein were not successful despite intensive screening of conditions; however, crystals were obtained for hDHTKD1 
Structural comparison of DHTKD1 with other E1 enzymes
Expectedly, a Dali search [31] reveals that the closest structural homologue to hDHTKD1 is msOGDH (z-score 55.7, rmsd 1.9 Å, 38% sequence identity) and ecOGDH (z 50.3, 1.8 Å, 40%).
The main structural divergence is found in their interdomain linkers, which traverse the respective 6 protein surface via different trajectories ( Fig. 1d ). Importantly, the hDHTKD1 linker packs against two loop regions that are longer than the equivalents in ecOGDH and msOGDH ( Fig. 1e ).
These include the 'active site loop' (aa 247-258), and a DHTKD1-unique region (aa 720-733) identified as 'Δ3' in [11] (Suppl. Fig. 3 ). The path traversed by the hDHTKD1 linker also overlaps with the binding sites for the allosteric activators of ecOGDH (acetyl-CoA, [27] ) and msOGDH (AMP, [28] ) revealed from their structures ( Fig. 1e, meshes) . These allosteric sites are likely not present in DHTKD1 structure, due to low sequence conservation in the neighbourhood.
To a lesser degree, hDHTKD1 is also structurally homologous to the E1 enzymes of human PDH and BCKDH (also known as 2-oxoisovalerate dehydrogenase) (z 30, 3.0-3.5 Å, 16%, [25, 26] ), which are heterotetramers built from two copies of two subunits ( Fig. 1f ). This contrasts with and BCKDH structures also contain K + binding sites that play a role in enzymatic regulation ( Fig.   1f , green spheres). We did not observe any difference density that suggests metal binding in the equivalent region of DHTKD1. Metal-dependent regulation is also featured in mammalian OGDH enzymes [32, 33] , mediated by Ca 2+ binding motifs unique to the OGDH N-terminus and a region equivalent to the DHTKD1 Δ 3 [34] . Again, these motifs are not present in prokaryotic
OGDHs, or DHTKD1.
The DHTKD1 active site favours 2OA as substrate
Each DHTKD1 subunit in the crystal homodimer is bound with a ThDP cofactor ( Fig. 1b,c) , at a site formed from both subunits (Suppl. Fig. 4 ). The ThDP pyrophosphate moiety binds to the α /β1 domain of one subunit, the pyrimidine ring binds to the α /β2 of the other subunit, while the central thiazolium ring sits between subunits. The ThDP binding residues are highly conserved among OGDH and E1 homologues (Suppl. Fig. 3 ). These include Asp333 and Asn366 which bridge the ThDP pyrophosphates with the Mg 2+ ion. Also, Leu290 acts as a hydrophobic wedge to form the characteristic V-shaped conformation of ThDP, bringing the N4' amino group of pyrimidine ring into close proximity (3.08 Å) with the C2 proton of thiazolium ring. Essential for catalysis, Glu640 triggers a proton relay to activate the cofactor into a reactive ylide (Suppl. Fig.   4 ). Reaction then ensues via a nucleophilic attack by the ThDP ylide on the substrate keto carbon of the substrate, forming a pre-decarboxylation intermediate that is in turn decarboxylated into an enamine-like ThDP adduct.
Compared to an apo E1 structure such as that of ecOGDH, our ThDP-bound DHTKD1 structure highlights 4 loop segments in the active site that undergo disorder-to-order transition during cofactor binding ( Fig. 2a ). Using nomenclature from ref [11] (Suppl. Fig. 4 ), these include: which contributes residues to engage with E2 enzyme for acyltransfer (e.g. His435). The conformations seen in our holo structure are similar to those of msOGDH structures bound with the post-decarboxylation cofactor conjugates [29] (Fig. 2b ).
In one x-ray dataset, we observed omit map electron density at one active site of the homodimer that is not accounted for by the cofactor or any component of the crystallisation condition (Suppl. DHTKD1 and OGDH overlap to some extent in their in vitro reactivity towards 2OG and 2OA [13, 35] . For example, soaking msOGDH crystals with 2OA and 2OG both yielded similar postdecarboxylation intermediates [29] . Nevertheless, hDHTKD1 turns over 2OA with 40-fold catalytic efficiency over 2OG [13] . The hDHTKD1 active site reveals several amino acids poised to interact with the substrate, but vary in sequence with OGDH orthologues. Two of them involve substitution to more polar residues i.e. Tyr190 (from Phe OGDH ) and Tyr370 (Phe OGDH ), while the other two to less bulky residues i.e Ser263 (Tyr OGDH ) and Asp707 (Glu OGDH ) (Suppl. Fig. 3 ).
Overlaying the two msOGDH post-decarboxylation intermediates (first and second conformers, sticks in Fig. 2b ; [29] ) onto the hDHTKD1 substrate pocket clearly explained how these substituted amino acids can stabilise catalytic intermediates generated from the longer 2OA substrate (Fig. 2c ). The 2OA terminal carboxyl group from the first conformer in msOGDH (PDB 3ZHT) can be sandwiched between hDHTKD1 Tyr190 (Phe OGDH ) and Tyr370 (Phe OGDH ) to form polar interactions, while hDHTKD1 Ser263 (Tyr OGDH ) and Asp707 (Glu OGDH ) increase pocket volume to accommodate the terminal carboxyl group from the second conformer in msOGDH (PDB 3ZHU). It remains to be determined whether the post-decarboxylation intermediate of hDHTKD1 also exists in dual conformation. Suffice it to rationalise that the DHTKD1 substrate pocket is engineered to accommodate the slightly larger and more polar 2OA substrate, providing a structural basis for its superior catalytic efficiency over 2OG.
DHTKD1 preferentially interacts with 2OA in solution
We further explored the substrate preference of hDHTKD1 by mapping its metabolite interactome using MIDAS, a mass spectrometry-based equilibrium dialysis approach [36] . From a screening library of 412 human metabolites, 2OA was observed as the most significant (p < 4.33x10 -54 , q < 2.59x10 -51 ) interaction with hDHTKD1 in the presence of ThDP and Mg 2+ ( Fig. 2d ). 
DHTKD1 and DLST form direct interactions
There is literature evidence that the E1 and E2 components of 2-oxoacid dehydrogenase complexes interact directly as a binary subcomplex, in the absence of E3. For some E1 enzymes such as OGDH and PDH, the N-terminus is known to be important for the direct interaction with E2 [38, 39] and E3 [40] , although this region is notably different for DHTKD1. For example, the hDHTKD1 precursor encodes a mere 50-aa segment before the first α -helix of the structure, while the hOGDH equivalent region is longer (121 aa) and contains two DLST-binding motifs [38] not preserved in DHTKD1 (Suppl. Fig. 1b ). This suggests that the manner in which DHTKD1 and OGDH (E1) interact with DLST (E2) could be different.
Human DLST as a precursor protein is structurally composed of ( . We opted to reconstitute the DHTKD1-DLST binary complex by co-expressing His-tagged hDHTKD1 and hDLST 68-453 in E. coli followed by affinity chromatography. Untagged hDLST 68-453 was found to co-purify with His-tagged hDHTKD1 45-919 immobilised on Ni affinity resin (Fig. 3b ), and to similar extent with hDHTKD1 1-919 ( Fig. 3c ) and hDHTKD1 (Fig. 3d , Suppl. Fig. 6 ). Hence the hDHTKD1 N-terminal 45 aa, not present in our structural model and replacing the DLSTbinding motifs mapped for hOGDH, does not play a role in the DHTKD1-DLST interaction. Size exclusion chromatography (SEC) using an analytical Superose 6 Increase column eluted the complex at V e = 10.4 ml, as compared to hDHTKD1 protein alone which eluted later at V e = 16.3 ml (Fig. 3d ). Our attempts to mix the binary DHTKD1-DLST complex with purified DLD did not yield a stable three-way complex in SEC, as was the case shown for OGDHc previously [38] .
Similar DHTKD1-DLST complex can also be formed by co-expression in the baculo Sf9 cells.
When expressed alone in Sf9, the hDLST 68-453 protein is highly prone to degradation, with a significant proportion fragmenting into two halves (Suppl. Fig. 7a ). When the DHTKD1 and DLST proteins are co-expressed, hDHTKD1 45-919 co-purified in SEC together with both the hDLST 68-453 intact protein and the C-terminal fragment (containing the catalytic core), while the N-terminal fragment (containing the lipoyl domain and linker) was not part of this complex (Suppl. Fig. 7b ). This suggests that the DLST N-terminal fragment alone is not sufficient to interact with DHTKD1, although this DLST region was previously mapped to be interacting with the binding motifs at the hOGDH-unique N-terminus [38] . Altogether, our data reinforce the notion that DHTKD1 and OGDH interact with DLST differently.
Insight into complex assembly from cryo-EM and SAXS studies
To provide a structural context for the DHTKD1-DLST interactions, we attempted single particle cryo-electron microscopy (cryo-EM) on the reconstituted binary complexes co-expressed in E.
coli and Sf9 cells. Electron micrographs showed the characteristic cubic cage structures (of approximate dimensions 130 Å x 130 Å x 130 Å), as observed in E. coli DLST [41] and other E2 enzymes such as A. vinelandii PDH E2 [42] and bovine BCKDH E2 [43] . Upon close inspection, we observed in the E. coli co-expressed complex more heterogenous particles, some of which reveal extra density emanating from the cubic core to approximately 10-20 Å (Suppl. Fig. 8a ).
This was not the case in the Sf9 co-expressed complex, where particles are more homogenous and contain only cubic cages (Suppl. Fig. 8b ). To date, we managed to collect a dataset of 33072 particles from the latter sample, and generated a 3D reconstruction at 5 Å resolution (Suppl. Fig.   9 ). This shows 24 DLST C-terminal catalytic domains assembled as eight trimer building blocks into a cubic cage with 432 symmetry (Fig. 3f ). Our EM map allows tracing of a humanised DLST model (aa 219-453 of human DLST) based on the E. coli structure (PDB 1E2O; 60% identity) [41] .
Considering the sequence conservation, the catalytic cores of E. coli and human DLST display essentially identical topology and symmetry along 2-, 3-and 4-fold axes (Fig. 3f ). In this assembly, all 24 C-terminal catalytic domains have their first residue (aa 219) exposed to the surface of the core (Fig. 3f, inset) , presumably projecting the adjacent inter-domain linker outwards from the core in order to deliver the N-terminal lipoyl domain for engagement with E1 and E3. We reasoned that the additional density protruding from the core in some of our cryo-EM grids (Suppl. Fig. 8a) represent an ordered segment of the linker region. Of the cryo-EM grids imaged thus far, there is unfortunately no discernible density for further regions of DLST (e.g. Nterminal lipoyl domain) or for the DHTKD1 protein. It is likely that the DLST lipoyl domain and much of the linker region are highly dynamic, in agreement with previous attempts to structurally characterize other full-length E2 enzymes such as human PDH E2 [44] . Additionally, the DHTKD1-DLST interaction could be short-lived, as shown for other E1-E2 complexes.
The positioning of 24 lipoyl domains at the exterior of the DLST core implies that they are all potentially available for engagement with E1 and E3. To explore the underlying stoichiometry for the DHTKD1-DLST interaction, we characterised the Sf9 co-expressed binary complex using SEC-SAXS (Suppl. Fig. 10 ). MW of hDHTKD1 :hDLST 68-453 derived from SAXS porod volume is 2.45 MDa, which is in close agreement with a MW of 2.7 MDa calculated for 24x
DLST and 16x DHTKD1 protomers, assuming a stoichiometry of one DHTKD1 dimer per DLST trimer building block, as suggested previously for hOGDHc [38] . It remains unknown whether the two active sites within a DHTKD1 dimer are engaged by one or two lipoyl domains. With either possibility, it is apparent that not all 24 lipoyl domains from one DLST core were engaged with DHTKD1 at the same time. are clustered in the α /β2 domain (Fig. 1a,c) . From >100 DHTKD1 and OGDH orthologues surveyed, the aa 715 position is invariantly Arg, while aa positions 305 and 777 are also highly conserved (82% and 93% respectively) ( Fig. 4a ). None of these residues directly affect the conserved catalytic machinery common to the 2-oxoacid dehydrogenase family.
Structural mapping of disease-causing DHTKD1 mutations
To understand their putative biochemical defects, we reconstructed the 7 DHTKD1 missense mutations recombinantly. All hDHTKD1 variants were expressed as soluble protein to similar level as wild-type (wt), with the exception of p.L234G and p.S777P which showed significantly lower yields and propensity to degradation, suggesting these variant proteins are misfolded, compared to wt (Fig. 4b, Suppl. Fig. 11 ). Leu234 is located at the protein centre ~20 Å from cofactor site (Fig. 4e) , and the p.L234G change introduces a smaller side-chain thereby leaving a cavity at the hydrophobic core ( Fig. 4f ). Ser777 is partially exposed to the protein surface (Fig. 4e) , and the p.S777P change introduces a proline side-chain that likely disrupts hydrogen bonds with neighbouring residues (Fig. 4g ).
The remainder 5 variant proteins were isolated, purified, and subjected to thermostability analysis by differential scanning fluorimetry. Four of them (p.Q305H, p.R455Q, p.R715C, p.G729R) demonstrated similar single unfolding-folding transition as hDHTKD1 wt (Fig. 4c, inset) .
However, p.P773L exhibited a significantly reduced melting temperature (ΔTm = -5.2 °C), suggesting that while expressed as soluble protein this variant is thermally more labile than wt ( Fig. 4c ). Pro773 forms a bend for the surface exposed loop which connects the α/β2 and α/β3 domains and also harbours the abovementioned Ser777. Replacing Pro773 with Leu likely alters the structural integrity of this loop (Fig. 4h ) and could affect protein folding. The observation of two destabilising mutations within this one loop region strongly implicates its importance in the functioning of DHTKD1.
Arg715 is located at the two-fold axis of the homodimer, and together with Arg712 forms a salt bridge network with Asp677 of the opposite subunit (Fig. 4h ). Arg712, Arg715 and Asp677 are invariant amino acid positions across DHTKD1 and OGDH orthologues, indicating the importance of this salt bridge network. Arg715 is positioned immediately after 'loop 3', a signature motif conserved across all E1 enzymes, including the invariant His708 that is involved in the reductive acyl transfer to E2 (Suppl. Fig. 3 ) [45] . SEC of the p.R715C variant revealed similar chromatogram profile as wt hDHTKD1 , indicating intact dimer formation (Suppl. Fig. 12 ). Nevertheless, when assayed in our co-expression and affinity pull-down, the hDHTKD1 45-919 p.R715C variant has significantly reduced ability to bind hDLST 68-453 directly (Fig. 4d, Suppl. Fig. 13 ), compared to wt (Fig. 3b) . Therefore the effect of p.R715C substitution could be transmitted from the dimer interface to engagement with E2 through loop 3. As control, hDHTKD1 45-919 bearing the p.R455Q or p.P773L substitution (both located at protein exterior)
interacts with hDLST 68-453 to similar extent as wt.
Our data did not reveal any discernible defects on protein stability or interaction with DLST in vitro for the p.Q305H, p.R455Q and p.G729R variants, the latter two being found in the majority of reported cases of 2-aminoadipic and 2-oxoadipic aciduria. These results imply that additional functions or unknown binding partners could be involved in the OADHc. Future efforts can be focussed on studying their in vivo impact using patient-relevant cells.
CONCLUSION
DHTKD1 is emerging as a key player in mitochondrial metabolism through its influence in lysine metabolism, energy production, and ROS balance. The structure of DHTKD1 presented here provides the first template for the rational design of DHTKD1 small molecule modulators, to probe the enzyme's role in these mitochondrial functions and the associated disease states.
DHTKD1 exhibits key structural differences from others E1 enzymes particularly OGDH, providing a molecular basis for the subtle difference in substrate specificity and protein-protein interaction despite their close homology. These features would likely be exploited by the DHTKD1-specific modulators.
We have reconstituted the DHTKD1-DLST complex in vitro, and demonstrated for the first time 
MATERIALS AND METHODS
Expression and purification of human DHTKD1 and DLST
Site-directed mutations were constructed using the QuikChange mutagenesis kit (Stratagene) and 
Co-expression of DHTKD1 and DLST
The DHTKD1-DLST complex used in this study was co-expressed in both E. coli and insect Sf9 cells. For E. coli co-expression, hDHTKD1 was subcloned into the pCDF-LIC vector (incorporating His-tag), and the resultant plasmid was co-transformed with the plasmid encoding untagged hDLST 68-453 in the pNIC-CT10HStII vector. Co-transformed cultures were grown and protein purification was performed as described above for DHTKD1 alone. For co-expression in insect cells, Sf9 culture was co-infected with one baculovirus expressing His-tagged hDHTKD1 and one baculovirus expressing His-tagged hDLST 68-453 .
Crystallization and structure determination of DHTKD1
Crystals were grown by vapour diffusion method. To crystalize hDHTKD1 and processed using the CCP4 program suite [46] . hDHTKD1 crystallized in the primitive space group P1 with two molecules in the asymmetric unit. The structure was solved by molecular replacement using the program PHASER [47] and the E. coli OGDH structure (PDB code 2JGD) as search model. The structure was refined using PHENIX [48] , followed by iterative cycles of model building in COOT [49] . Statistics for data collection and refinement are summarized in Table 1 .
DHTKD1 enzyme assay
The enzymatic activity assay was performed in a buffer containing 35 SAXS data were processed and analyzed using the ATSAS program package [52] and Scatter (http://www.bioisis.net/scatter). The radius of gyration Rg and forward scattering I(0) were calculated by Guinier approximation. The maximum particle dimension Dmax and P(r) function were evaluated using the program GNOM [53] .
Solution Analysis
Analytical T m , were determined as described [54] and final graphs were generated using GraphPad Prism (v.7; Graph-Pad Software). Assays were carried out in technical triplicate.
MIDAS protein-metabolite screening
Protein-metabolite interaction screening using an updated MIDAS platform was performed similar to Orsak, et al [36] . FIA-MS spectra collected from MIDAS protein-metabolite screening was qualitatively and quantitatively processed in SCIEX OS 1.5 software to determine relative metabolite abundance by integrating the mean area under the curve (AUC) across technical triplicates. 
Grid preparation and data acquisition
EM data collection and processing
A total of 619 dose-fractioned movies were beam-induced motion correction using MotionCor2 [55] with the dose-weighting option. CTF parameters were determined by ctffind4.1 [56] . The DLST particles were auto-picked using Relion 3.0 [57] . A total of 165739 particles were then extracted with a box size of 344 pixels rescaled to 172 pixels (2x binning). Particles were filtered for homogeneity using rounds of 2D, 3D classification with Relion 3.0 [57] . 33,072 particles where re-extracted un-binned and submitted to 3D auto-refinement with O (octahedral) symmetry imposed resulting in a 5 Å map after post processing (Suppl. Fig. 10a ). 3D refinements were started from a 50 Å low-pass filtered version of a 3D class map from previous step. Global resolution was estimated by applying a soft mask around the protein complex density and based on the gold-standard (two halves of data refined independently) FSC = 0.143 criterion (Suppl. Fig. 10b ). Local resolution was calculated with relion 3.0 [57] (Suppl. Fig. 10c ).
EM Model building and refinement
To fit a template to the final map the E.coli DLST orthologue structure (PDB 1SCZ) was used.
The sequence was humanized and residues truncated to the alpha carbon using Chainsaw [58] .
The oligomeric structure was docked into the O symmetry full EM density map using Molrep followed by one round of refinement using refmac5 through CCP-EM [59] . Fig. 5 and Suppl. Fig.   10 were made using Chimera [60] . (e) Chromatogram and SDS-PAGE from size exclusion chromatography runs of hDHTKD1 protein alone (dashed line), and of hDHTKD1 45-919 co-expressed with hDLST 68-453 . Elution volumes for the complex peak and hDHTKD1-alone peak are shown. (f) EM Map of the hDLST 24-mer catalytic core, overlaid with a humanized model of E. coli DLST (PDB 1SCZ). The three views show how the trimer building block (monomers shown as blue, orange and green ribbons) are assembled into the 24-mer core via four-fold (left), two-fold (middle) and three-fold (right) symmetry axes respectively. Inset of the left view shows how the first residue (aa 219, red spheres) from each of the 24 hDLST catalytic cores are distributed at the surface of the cube structure. 
